Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients.


Journal

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
ISSN: 1600-6143
Titre abrégé: Am J Transplant
Pays: United States
ID NLM: 100968638

Informations de publication

Date de publication:
07 2022
Historique:
revised: 24 03 2022
received: 04 02 2022
accepted: 01 04 2022
pubmed: 7 4 2022
medline: 7 7 2022
entrez: 6 4 2022
Statut: ppublish

Résumé

Seroconversion after COVID-19 vaccination is impaired in kidney transplant recipients. Emerging variants of concern such as the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants pose an increasing threat to these patients. In this observational cohort study, we measured anti-S1 IgG, surrogate neutralizing, and anti-receptor-binding domain antibodies three weeks after a third mRNA vaccine dose in 49 kidney transplant recipients and compared results to 25 age-matched healthy controls. In addition, vaccine-induced neutralization of SARS-CoV-2 wild-type, the B.1.617.2 (delta), and the B.1.1.529 (omicron) variants was assessed using a live-virus assay. After a third vaccine dose, anti-S1 IgG, surrogate neutralizing, and anti-receptor-binding domain antibodies were significantly lower in kidney transplant recipients compared to healthy controls. Only 29/49 (59%) sera of kidney transplant recipients contained neutralizing antibodies against the SARS-CoV-2 wild-type or the B.1.617.2 (delta) variant and neutralization titers were significantly reduced compared to healthy controls (p < 0.001). Vaccine-induced cross-neutralization of the B.1.1.529 (omicron) variants was detectable in 15/35 (43%) kidney transplant recipients with seropositivity for anti-S1 IgG, surrogate neutralizing, and/or anti-RBD antibodies. Neutralization of the B.1.1.529 (omicron) variants was significantly reduced compared to neutralization of SARS-CoV-2 wild-type or the B.1.617.2 (delta) variant for both, kidney transplant recipients and healthy controls (p < .001 for all).

Identifiants

pubmed: 35384272
doi: 10.1111/ajt.17054
pmc: PMC9111366
pii: S1600-6135(22)08276-4
doi:

Substances chimiques

Antibodies, Neutralizing 0
Antibodies, Viral 0
COVID-19 Vaccines 0
Immunoglobulin G 0
RNA, Messenger 0
Vaccines, Synthetic 0
Viral Envelope Proteins 0
mRNA Vaccines 0

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1873-1883

Informations de copyright

© 2022 The Authors. American Journal of Transplantation published by Wiley Periodicals LLC on behalf of The American Society of Transplantation and the American Society of Transplant Surgeons.

Références

JAMA Pediatr. 2021 Jun 1;175(6):586-593
pubmed: 33480966
Front Immunol. 2022 Mar 04;13:840136
pubmed: 35309320
Cell. 2022 Feb 3;185(3):447-456.e11
pubmed: 35026151
Bioinformatics. 2019 Jul 15;35(14):2489-2491
pubmed: 30520945
Clin J Am Soc Nephrol. 2021 Jul;16(7):1073-1082
pubmed: 34031181
Am J Transplant. 2021 Dec;21(12):4043-4051
pubmed: 34431207
Front Med (Lausanne). 2021 Aug 17;8:721286
pubmed: 34485347
J Am Soc Nephrol. 2021 Dec 1;32(12):3027-3033
pubmed: 34667083
J Infect Dis. 2021 Mar 3;223(5):796-801
pubmed: 33064789
Liver Int. 2022 Jan;42(1):180-186
pubmed: 34719107
Ann Intern Med. 2022 Feb;175(2):226-233
pubmed: 34807716
Transplantation. 2021 Jan 1;105(1):79-89
pubmed: 33273320
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Cell. 2021 Feb 18;184(4):861-880
pubmed: 33497610
Neurology. 2022 Feb 1;98(5):e541-e554
pubmed: 34810244
Front Immunol. 2021 Sep 14;12:740249
pubmed: 34594343
Vaccines (Basel). 2021 Aug 04;9(8):
pubmed: 34451982
Kidney Int. 2021 Sep;100(3):700-702
pubmed: 34265359
Lancet Reg Health Eur. 2021 Oct;9:100178
pubmed: 34318288
Lancet. 2021 Jul 31;398(10298):385-387
pubmed: 34274038
Clin Microbiol Infect. 2022 Jul;28(7):1024.e7-1024.e12
pubmed: 35124261
Clin J Am Soc Nephrol. 2022 Jan;17(1):98-106
pubmed: 34937771
Nat Commun. 2021 Nov 4;12(1):6379
pubmed: 34737312
Genome Biol. 2016 Jun 06;17(1):122
pubmed: 27268795
N Engl J Med. 2022 Feb 3;386(5):494-496
pubmed: 34965358
Kidney Int. 2022 Mar;101(3):639-642
pubmed: 34954213
Cell. 2020 Nov 12;183(4):996-1012.e19
pubmed: 33010815
Am J Transplant. 2022 Feb;22(2):634-639
pubmed: 34551181
N Engl J Med. 2021 Aug 12;385(7):661-662
pubmed: 34161700
Nature. 2022 Feb;602(7898):671-675
pubmed: 35016199
JAMA. 2021 Jul 23;:
pubmed: 34297036
Ann Rheum Dis. 2022 Apr;81(4):593-595
pubmed: 35012926
Microorganisms. 2021 Jun 16;9(6):
pubmed: 34208751
Am J Transplant. 2022 Jan;22(1):322-323
pubmed: 34331842
Am J Transplant. 2021 Dec;21(12):3980-3989
pubmed: 34347934
Cell Rep. 2021 Feb 9;34(6):108728
pubmed: 33516277
N Engl J Med. 2021 Dec 9;385(24):e84
pubmed: 34614326
Vaccines (Basel). 2021 Oct 04;9(10):
pubmed: 34696238
Am J Transplant. 2022 Aug;22(8):2089-2093
pubmed: 35266606
J Clin Med. 2022 Mar 21;11(6):
pubmed: 35330069
Transplantation. 2022 Mar 1;106(3):436-446
pubmed: 34982758
Nat Biotechnol. 2020 Sep;38(9):1073-1078
pubmed: 32704169
N Engl J Med. 2022 Feb 3;386(5):492-494
pubmed: 34965337
N Engl J Med. 2021 Nov 18;385(21):1941-1950
pubmed: 34706189
Science. 2022 May 6;376(6593):eabn4947
pubmed: 35289632
Cell. 2022 Mar 3;185(5):847-859.e11
pubmed: 35139340
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Clin Microbiol Infect. 2021 Feb;27(2):286.e7-286.e13
pubmed: 33045370
Transplantation. 2021 Nov 1;105(11):e265-e266
pubmed: 34310531
N Engl J Med. 2022 Feb 10;386(6):599-601
pubmed: 35030645
Genome Biol. 2014 Mar 03;15(3):R46
pubmed: 24580807
Bioinformatics. 2011 Nov 1;27(21):2987-93
pubmed: 21903627
JAMA Netw Open. 2021 Nov 1;4(11):e2136030
pubmed: 34817587
Nat Med. 2021 Jul;27(7):1205-1211
pubmed: 34002089
JAMA Intern Med. 2022 Feb 1;182(2):165-171
pubmed: 34928302
Nature. 2022 Feb;602(7898):676-681
pubmed: 35016198
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Transplantation. 2021 Dec 1;105(12):e280-e281
pubmed: 34428188
Ann Intern Med. 2021 Sep;174(9):1330-1332
pubmed: 34125572
Genome Biol. 2019 Jan 8;20(1):8
pubmed: 30621750
Kidney Int. 2022 Mar;101(3):642-645
pubmed: 34890687
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
JAMA. 2021 Jun 1;325(21):2204-2206
pubmed: 33950155

Auteurs

Louise Benning (L)

Department of Nephrology, University of Heidelberg, Heidelberg, Germany.

Christian Morath (C)

Department of Nephrology, University of Heidelberg, Heidelberg, Germany.

Marie Bartenschlager (M)

Department of Infectious Diseases, Molecular Virology, University of Heidelberg, Heidelberg, Germany.

Heeyoung Kim (H)

Department of Infectious Diseases, Molecular Virology, University of Heidelberg, Heidelberg, Germany.

Marvin Reineke (M)

Department of Nephrology, University of Heidelberg, Heidelberg, Germany.

Jörg Beimler (J)

Department of Nephrology, University of Heidelberg, Heidelberg, Germany.

Mirabel Buylaert (M)

Department of Nephrology, University of Heidelberg, Heidelberg, Germany.

Christian Nusshag (C)

Department of Nephrology, University of Heidelberg, Heidelberg, Germany.

Florian Kälble (F)

Department of Nephrology, University of Heidelberg, Heidelberg, Germany.

Paula Reichel (P)

Department of Nephrology, University of Heidelberg, Heidelberg, Germany.

Maximilian Töllner (M)

Department of Nephrology, University of Heidelberg, Heidelberg, Germany.

Matthias Schaier (M)

Department of Nephrology, University of Heidelberg, Heidelberg, Germany.

Katrin Klein (K)

Department of Nephrology, University of Heidelberg, Heidelberg, Germany.

Vladimir Benes (V)

Genomics Core Facility, European Molecular Biology Laboratory, Heidelberg, Germany.

Tobias Rausch (T)

Genomics Core Facility, European Molecular Biology Laboratory, Heidelberg, Germany.

Susanne Rieger (S)

Department of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.

Maximilian Stich (M)

Department of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.

Burkhard Tönshoff (B)

Department of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.

Niklas Weidner (N)

Department of Virology, University of Heidelberg, Heidelberg, Germany.

Paul Schnitzler (P)

Department of Virology, University of Heidelberg, Heidelberg, Germany.

Martin Zeier (M)

Department of Nephrology, University of Heidelberg, Heidelberg, Germany.

Caner Süsal (C)

Institute of Immunology, University of Heidelberg, Heidelberg, Germany.
Transplant Immunology Research Center of Excellence, Koç University Hospital, Istanbul, Turkey.

Thuong Hien Tran (T)

Institute of Immunology, University of Heidelberg, Heidelberg, Germany.

Ralf Bartenschlager (R)

Department of Infectious Diseases, Molecular Virology, University of Heidelberg, Heidelberg, Germany.
German Center for Infection Research, Heidelberg, Germany.
Division Virus-Associated Carcinogenesis, German Cancer Research Center, Heidelberg, Germany.

Claudius Speer (C)

Department of Nephrology, University of Heidelberg, Heidelberg, Germany.
Department of Molecular Medicine Partnership Unit Heidelberg, European Molecular Biology Laboratory, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH